Abstract:AIM: To evaluate the efficacy of itraconazole injection and oral solution for the treatment of central nervous system ( CNS) fungal infection, and its safety in combination with amphotericin B, and/or flucytosine. METHODS: Seventeen patients admitted to our hospital with CNS fungal infection were enrolled in an open-label clinical trial from June 2004 to September 2005. They were treated with itraconazole alone or combined with amphotericine B, and/or flucytosine. In this study, patients were treated with itraconazole injection (d 1 - 2, 200 mg, q 12 h; d 3 - 14, 200 mg·d-1) for a minimum of 7 d were included in the efficacy eval- After treated with intraconazole injection, the patients were followed by administration of intraconazole oral solution, and/or in combination with amphotericine B slow intravenouse infusion or flucytosine taken orally. RESULTS: A total of 17 patients included definite (n = 14) or probable (n = 3) CNS fungal infection were enrolled. The identified fungi were Cryptococcus neoformans, Aspergillus spp., and Prototheca wickerhamii. All the patients had headache, fever, and higher than 300 mmH2O intracranial pressure, including 7 patients with underlying diseases, 7 patients with complication of coma and 10 patients with cerebral herniation. Six patients underwent Ommaya-reservoir and ventricular shunt operations. Overall, two patients died at 2 d after the therapy excluding from the efficacy evaluation. The rest 15 patients included 11 (11/15, 73%) with excellent response to this remedy consisting of one with cerebral aspergilloma, one with aspergillus meningitis, one with prototheca wickerhamii meningitis, two with cerebral cryptococcoma, and six with cryptococcal meningitis, only three of them were treated with itraconazole alone. Three patients with cryptococcal meningitis showed partial response and one failed. All patients tolerated well with itraconazole. The adverse reactions including only 2 of mild liver function disorder probably due to intravenous administration and 3 of mild to moderate nausea, loss of appetite after oral intake more than 2 mo. CONCLUSION: Itraconazole injection and oral solution show impressive curing activity on CNS fungal infection together with safety on either itraconazole alone or combined with other antifungal drugs (amphotericine B, and/or flucytosine) .

Itraconazole Oral Solution in Treatment of Oral Candidiasis in 40 Patients

A Clinical Trial of Intravenous Itraconazole Followed by Itraconazole Capsule in the Treatment of 25 Cases of Systemic Fungal Infection

Terbinafine versus itraconazole for treatment of dermatophyte onychomycosis: a meta-analysis

Efficacy and Safety of Itraconazole on Invasive Fungal Infections in 66 Patients with Malignant Hematological Diseases

In Vitro Interaction of Itraconazole with Amphotericin B, Caspofungin, and Terbinafine Against Clinical Isolates of Trichosporon asahii

Efficacy and Safety of Itraconazole As Empirical Antifungal Therapy in Febrile Neutropenic Patients with Hematologic Malignancies: an Open-Lable, Multicenter, Observational Trial in A Chinese Cohort

A Multicenter, Open-Label Study of Posaconazole Oral Suspension in the Treatment of Invasive Fungal Infections in Patients Refractory to or Intolerant of First-Line Therapy.

The Efficacy and Safety of Miconazole Nitrate Mucoadhesive Tablets Versus Itraconazole Capsules in the Treatment of Oral Candidiasis: an Open-Label, Randomized, Multicenter Trial.

Itraconazole Injection/oral Solution Therapy for Central Nervous System Fungal Infection: an Open Clinical Study

Clinical study on the efficacy and safety of intravenous itraconazole infusion for the treatment of invasive fungal infection in China

A Multicenter, Open-Label Study of Posaconazole Oral Suspension in Treatment of Patients with Invasive Fungal Infection Refractory to or Intolerant of First-Line Therapy,

Efficacy and safety of miconazole muco-adhesive tablet versus itraconazole in oropharyngeal candidiasis: A randomized, multi-centered, double-blind, phase 3 trial

Progress in Clinical Research of Itraconazole in the Treatment of Vulvovaginal Candidiasis

Efficacy and Safety of Caspofungin Followed by Itraconazole Oral Solution for Patients with Invasive Fungal Infection

Clinical Efficacy of Itraconazole in the Treatment of Invasive Fungal Infections in Patients of Intensive Care Unit

[Hepatic Safety of Itraconazole Intravenous Solution in Treatment of Invasive Fungal Infection].

A Randomized Control Study of Oral Itraconazole versus Itraconazole with Terbinafine in the Treatment of Dermatophytosis

Treatment of onychomycosis by pulse usage of itraconazole

Clinical analysis on the effect of itraconazole oral solution versus fluconazole in the prevention of fungal infection in neutropenic patients with acute leukemia

[Efficacy of Intravenous Administration of Itraconazole on Fungal Infections in Immunocompromised Patients with Hematological Diseases].

A Retrospective Study of Efficacy and Safety of Itraconazole for Treatment of Invasive Fungal Infection in Hematologic Diseases